.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Deloitte
McKesson
AstraZeneca
Argus Health
Express Scripts
Accenture
Julphar
Farmers Insurance
Fuji

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075574

« Back to Dashboard
NDA 075574 describes DOXAZOSIN MESYLATE, which is a drug marketed by Mylan, Nesher Pharms, Zydus Pharms Usa Inc, Accord Hlthcare, Watson Labs Inc, Idt Australia Ltd, Teva, Sandoz, Pliva, Ivax Sub Teva Pharms, Dava Pharms Inc, Genpharm, Actavis Elizabeth, and Apotex, and is included in fifteen NDAs. It is available from thirty-three suppliers. Additional details are available on the DOXAZOSIN MESYLATE profile page.

The generic ingredient in DOXAZOSIN MESYLATE is doxazosin mesylate. There are thirteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.

Summary for 075574

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Genitourinary Agents
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 075574

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 1MG BASE
Approval Date:Oct 18, 2000TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 2MG BASE
Approval Date:Oct 18, 2000TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 4MG BASE
Approval Date:Oct 18, 2000TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Cerilliant
Cantor Fitzgerald
QuintilesIMS
Federal Trade Commission
Baxter
Express Scripts
Fuji
Teva
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot